Microglia and macrophages in malignant gliomas: Recent discoveries and implications for promising therapies

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Carvalho Da Fonseca, Anna Carolina ^a   Badie, Behnam ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CARBON NANOTUBE; CHEMOKINE; CHEMOKINE RECEPTOR CX3CR1; CYCLODEXTRIN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1BETA; INTERLEUKIN 8; MATRIX METALLOPROTEINASE 14; MATRIX PROTEIN; METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOSHELL; NEUROTENSIN; PROTEIN S 100; RANTES; S ADENOSYLHOMOCYSTEINE; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5; ANTIBODY; CCL2 PROTEIN, HUMAN; SMALL INTERFERING RNA; STAT3 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER INHIBITION; CANCER STEM CELL; CONTROLLED STUDY; EMBRYO; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TUMOR GROWTH; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CELL COMMUNICATION; CHEMOTAXIS; DRUG EFFECTS; GENETICS; GLIOMA; IMMUNOLOGY; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIBODIES; BRAIN NEOPLASMS; CELL COMMUNICATION; CHEMOKINE CCL2; CHEMOTAXIS; GLIOMA; HUMANS; INTEGRIN ALPHA5BETA1; MACROPHAGES; MICROGLIA; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TUMOR MICROENVIRONMENT;

EID: 84891441830     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/264124     Document Type: Review

References (54)

1. Dolecek T. A., Propp J. M., Stroup N. E., Kruchko C., CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology 2012 14 supplement 5 v1 v49
2. Lima F. R., Kahn S. A., Soletti R. C., Glioblastoma: therapeutic challenges, what lies ahead. Biochimica et Biophysica Acta 2012 1826 338 349
3. Muldoon L. L., Soussain C., Jahnke K., Johanson C., Siegal T., Smith Q. R., Hall W. A., Hynynen K., Senter P. D., Peereboom D. M., Neuwelt E. A., Chemotherapy delivery issues in central nervous system malignancy: a reality check. Journal of Clinical Oncology 2007 25 16 2295 2305 2-s2.0-34250182404 10.1200/JCO.2006.09.9861 (Pubitemid 46954658)
4. Stupp R., Mason W. P., Van Den Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine 2005 352 10 987 996 2-s2.0-20044366163 10.1056/NEJMoa043330 (Pubitemid 40349501)
5. Kushchayev S. V., Kushchayeva Y. S., Wiener P. C., Badie B., Preul M. C., Monocyte-derived cells of the brain and malignant gliomas: the double face of Janus. World Neurosurgery 2012 10.1016/j.wneu.2012.11.059
6. Badie B., Schartner J. M., Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 2000 46 4 957 962 2-s2.0-0034093158 (Pubitemid 30198803)
7. Yang I., Han S. J., Kaur G., Crane C., Parsa A. T., The role of microglia in central nervous system immunity and glioma immunology. Journal of Clinical Neuroscience 2010 17 1 6 10 2-s2.0-72449154567 10.1016/j.jocn.2009.05.006
8. Charles N. A., Holland E. C., Gilbertson R., Glass R., Kettenmann H., The brain tumor microenvironment. GLIA 2011 59 8 1169 1180 2-s2.0-79957926996 10.1002/glia.21136
9. Badie B., Schartner J., Klaver J., Vorpahl J., In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 1999 44 5 1077 1083 2-s2.0-0032931667 10.1097/00006123-199905000-00075 (Pubitemid 29202868)
10. Coniglio S. J., Eugenin E., Dobrenis K., Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Molecular Medicine 2012 18 519 527
11. Held-Feindt J., Hattermann K., Müerköster S. S., Wedderkopp H., Knerlich-Lukoschus F., Ungefroren H., Mehdorn H. M., Mentlein R., CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Experimental Cell Research 2010 316 9 1553 1566 2-s2.0-77952890503 10.1016/j.yexcr.2010.02.018
12. Okada M., Saio M., Kito Y., Ohe N., Yano H., Yoshimura S., Iwama T., Takami T., Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. International Journal of Oncology 2009 34 6 1621 1627 2-s2.0-67649448823 10.3892/ijo-00000292
13. Wang S.-C., Hong J.-H., Hsueh C., Chiang C.-S., Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Laboratory Investigation 2012 92 1 151 162 2-s2.0-84855251694 10.1038/labinvest.2011.128
14. Desbaillets I., Tada M., De Tribolet N., Diserens A.-C., Hamou M.-F., Van Meir E. G., Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. International Journal of Cancer 1994 58 2 240 247 2-s2.0-0027959172 10.1002/ijc.2910580216 (Pubitemid 24240102)
15. Jantaratnotai N., Choi H. B., McLarnon J. G., ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells. BMC Cancer 2009 9, article 442 2-s2.0-74549117714 10.1186/1471-2407-9-442
16. Wang H., Zhang L., Zhang I. Y., S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages. Clinical Cancer Research 2013 10.1158/1078-0432.CCR-12-3725
17. Kioi M., Vogel H., Schultz G., Hoffman R. M., Harsh G. R., Brown J. M., Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. Journal of Clinical Investigation 2010 120 3 694 705 2-s2.0-77949697909 10.1172/JCI40283
18. Jacobs V. L., Liu Y., De Leo J. A., Propentofylline targets TROY, a novel microglial signaling pathway. PLoS ONE 2012 7 e37955
19. Yi L., Xiao H., Xu M., Ye X., Hu J., Li F., Li M., Luo C., Yu S., Bian X., Feng H., Glioma-initiating cells: a predominant role in microglia/ macrophages tropism to glioma. Journal of Neuroimmunology 2011 232 1-2 75 82 2-s2.0-79952250124 10.1016/j.jneuroim.2010.10.011
20. Wu A., Wei J., Kong L.-Y., Wang Y., Priebe W., Qiao W., Sawaya R., Heimberger A. B., Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-Oncology 2010 12 11 1113 1125 2-s2.0-78049270536 10.1093/neuonc/noq082
21. Komohara Y., Ohnishi K., Kuratsu J., Takeya M., Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. Journal of Pathology 2008 216 1 15 24 2-s2.0-50249144131 10.1002/path.2370
22. Albesiano E., Han J. E., Lim M., Mechanisms of local immunoresistance in glioma. Neurosurgery Clinics of North America 2010 21 1 17 29 2-s2.0-70450205329 10.1016/j.nec.2009.08.008
23. Zhang L., Liu W., Alizadeh D., Zhao D., Farrukh O., Lin J., Badie S. A., Badie B., S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway. GLIA 2011 59 3 486 498 2-s2.0-78751700661 10.1002/glia.21118
24. Yu H., Pardoll D., Jove R., STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews Cancer 2009 9 11 798 809 2-s2.0-70350500225 10.1038/nrc2734
25. Kiefer R., Supler M. L., Toyka K. V., Streit W. J., In situ detection of transforming growth factor- β mRNA in experimental rat glioma and reactive glial cells. Neuroscience Letters 1994 166 2 161 164 2-s2.0-0028006348 10.1016/0304-3940(94)90475-8 (Pubitemid 24053818)
26. Wesolowska A., Kwiatkowska A., Slomnicki L., Dembinski M., Master A., Sliwa M., Franciszkiewicz K., Chouaib S., Kaminska B., Microglia-derived TGF- β as an important regulator of glioblastoma invasion-an inhibition of TGF- β -dependent effects by shRNA against human TGF- β type II receptor. Oncogene 2008 27 7 918 930 2-s2.0-38949165993 10.1038/sj.onc.1210683 (Pubitemid 351225378)
27. Ye X. Z., Xu S. L., Xin Y. H., Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. Journal of Immunology 2012 189 444 453
28. Lin H.-C., Song T.-Y., Hu M.-L., S-Adenosylhomocysteine promotes the invasion of C6 glioma cells via increased secretion of matrix metalloproteinase-2 in murine microglial BV2 cells. Toxicological Sciences 2009 112 2 322 330 2-s2.0-74949089273 10.1093/toxsci/kfp218
29. Markovic D. S., Vinnakota K., Chirasani S., Synowitz M., Raguet H., Stock K., Sliwa M., Lehmann S., Kälin R., Van Rooijen N., Holmbeck K., Heppner F. L., Kiwit J., Matyash V., Lehnardt S., Kaminska B., Glass R., Kettenmann H., Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proceedings of the National Academy of Sciences of the United States of America 2009 106 30 12530 12535 2-s2.0-68149169092 10.1073/pnas.0804273106
30. Zhang J., Sarkar S., Cua R., Zhou Y., Hader W., Wee Yong V., A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis. Carcinogenesis 2012 33 2 312 319 2-s2.0-84856583560 10.1093/carcin/bgr289
31. Jain R. K., Di Tomaso E., Duda D. G., Loeffler J. S., Sorensen A. G., Batchelor T. T., Angiogenesis in brain tumours. Nature Reviews Neuroscience 2007 8 8 610 622 2-s2.0-34447632643 10.1038/nrn2175 (Pubitemid 47093931)
32. Kerber M., Reiss Y., Wickersheim A., Jugold M., Kiessling F., Heil M., Tchaikovski V., Waltenberger J., Shibuya M., Plate K. H., Machein M. R., Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Research 2008 68 18 7342 7351 2-s2.0-54749092522 10.1158/0008-5472.CAN-07-6241
33. da Fonseca A. C. C., Romão L., Amaral R. F., Assad Kahn S., Lobo D., Martins S., Marcondes de Souza J., Moura-Neto V., Lima F. R. S., Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells. Neuroscience 2012 200 130 141 2-s2.0-84855188858 10.1016/j.neuroscience.2011.10.025
34. Zhang L., Alizadeh D., van Handel M., Kortylewski M., Yu H., Badie B., Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. GLIA 2009 57 13 1458 1467 2-s2.0-70349097179 10.1002/glia.20863
35. Fujiwara Y., Komohara Y., Ikeda T., Takeya M., Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer Science 2011 102 1 206 211 2-s2.0-78650218768 10.1111/j.1349-7006.2010.01772.x
36. Fujiwara Y., Komohara Y., Kudo R., Tsurushima K., Ohnishi K., Ikeda T., Takeya M., Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncology Reports 2011 26 6 1533 1537 2-s2.0-80053516019 10.3892/or.2011.1454
37. Zhu X., Fujita M., Snyder L. A., Okada H., Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy. Journal of Neuro-Oncology 2011 104 1 83 92 2-s2.0-80052746486 10.1007/s11060-010-0473-5
38. He J., Yin Y., Luster T. A., Watkins L., Thorpe P. E., Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clinical Cancer Research 2009 15 22 6871 6880 2-s2.0-72549108621 10.1158/1078-0432.CCR- 09-1499
39. Alizadeh D., Zhang L., Hwang J., Schluep T., Badie B., Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. Nanomedicine 2010 6 382 390
40. VanHandel M., Alizadeh D., Zhang L., Kateb B., Bronikowski M., Manohara H., Badie B., Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model. Journal of Neuroimmunology 2009 208 1-2 3 9 2-s2.0-62749152720 10.1016/j.jneuroim.2008.12.006
41. Zhao D., Alizadeh D., Zhang L., Liu W., Farrukh O., Manuel E., Diamond D. J., Badie B., Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clinical Cancer Research 2011 17 4 771 782 2-s2.0-79951842455 10.1158/1078-0432.CCR-10-2444
42. Kopatz J., Beutner C., Welle K., Siglec-h on activated microglia for recognition and engulfment of glioma cells. GLIA 2013 10.1002/glia.22501
43. Ribot E. J., Miraux S., Konsman J. P., Bouchaud V., Pourtau L., Delville M.-H., Franconi J.-M., Thiaudière E., Voisin P. J., In vivo MR tracking of therapeutic microglia to a human glioma model. NMR in Biomedicine 2011 24 10 1361 1368 2-s2.0-81155129275 10.1002/nbm.1699
44. Baek S.-K., Makkouk A. R., Krasieva T., Sun C.-H., Madsen S. J., Hirschberg H., Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells. Journal of Neuro-Oncology 2011 104 2 439 448 2-s2.0-80052642756 10.1007/s11060-010-0511-3
45. Markovic D. S., Vinnakota K., van Rooijen N., Kiwit J., Synowitz M., Glass R., Kettenmann H., Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain, Behavior, and Immunity 2011 25 4 624 628 2-s2.0-79954741725 10.1016/j.bbi.2011.01.015
46. Yeung Y. T., Bryce N. S., Adams S., Braidy N., Konayagi M., McDonald K. L., Teo C., Guillemin G. J., Grewal T., Munoz L., p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. Journal of Neuro-Oncology 2012 109 35 44 2-s2.0-84859912861 10.1007/s11060-012-0875-7
47. Gabrusiewicz K., Ellert-Miklaszewska A., Lipko M., Sielska M., Frankowska M., Kaminska B., Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS ONE 2011 6 8 2-s2.0-80052069274 10.1371/journal.pone.0023902 e23902
48. Jacobs V. L., Landry R. P., Liu Y., Romero-Sandoval E. A., De Leo J. A., Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro-Oncology 2012 14 2 119 131 2-s2.0-84859518369 10.1093/neuonc/nor194
49. Chiu T.-L., Peng C.-W., Wang M.-J., Enhanced anti-glioblastoma activity of microglia by AAV2-mediated IL-12 through TRAIL and phagocytosis in vitro. Oncology Reports 2011 25 5 1373 1380 2-s2.0-79953053268 10.3892/or.2011.1213
50. Kees T., Lohr J., Noack J., Mora R., Gdynia G., Tödt G., Ernst A., Radlwimmer B., Falk C. S., Herold-Mende C., Régnier-Vigouroux A., Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. Neuro-Oncology 2012 14 1 64 78 2-s2.0-84856292648 10.1093/neuonc/nor182
51. Nagai T., Tanaka M., Tsuneyoshi Y., Xu B., Michie S. A., Hasui K., Hirano H., Arita K., Matsuyama T., Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta. Cancer Immunology, Immunotherapy 2009 58 10 1577 1586 2-s2.0-68549104285 10.1007/s00262-009-0667-x
52. Färber K., Synowitz M., Zahn G., Vossmeyer D., Stragies R., van Rooijen N., Kettenmann H., An α 5 β 1 integrin inhibitor attenuates glioma growth. Molecular and Cellular Neuroscience 2008 39 4 579 585 2-s2.0-56249095776 10.1016/j.mcn.2008.08.005
53. Kennedy B. C., Maier L. M., D'Amico R., Mandigo C. E., Fontana E. J., Waziri A., Assanah M. C., Canoll P., Anderson R. C. E., Anderson D. E., Bruce J. N., Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunology 2009 10, article 11 2-s2.0-62749198722 10.1186/1471-2172-10-11
54. Wu Y., Lu Y., Chen W., Fu J., Fan R., In silico experimentation of glioma microenvironment development and anti-tumor therapy. PLOS Computational Biology 2012 8 e1002355